Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05014880

Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation

Impact of Time Restricted Eating on Exercise Capacity, Cardiometabolic Parameters, and Trimethylamine N-oxide (TMAO) Levels in Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if reducing the number of hours during which one eats each day will help reduce levels of LDL cholesterol and improve other markers of metabolic and cardiovascular health (i.e. blood sugar levels and blood pressure). The study also aims to assess changes in exercise capacity and trimethylamine N-oxide (TMAO) levels in response to Time Restricted Eating (TRE) and Intensive Cardiac Rehabilitation (ICR) versus ICR alone. TMAO is a metabolite, or a substance, produced during digestion and metabolism. Preliminary data illustrates a correlation between high levels of TMAO and higher risk of cardiovascular disease and mortality. We will also be looking at participants' long-term cardiovascular health status after they complete the ICR program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALICR (Intensive Cardiac Rehabilitation)Participants in this arm will not have to adopt a 10-hour eating window while taking part in UCSD's 9-week ICR program.
BEHAVIORALICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)Participants in this arm will adhere to a daily, consistent 10-hour eating window while undergoing UCSD's 9-week ICR program to see if there is an improvement on cardiometabolic parameters.

Timeline

Start date
2021-09-02
Primary completion
2023-09-11
Completion
2025-01-31
First posted
2021-08-20
Last updated
2024-08-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05014880. Inclusion in this directory is not an endorsement.